UBS Maintains Sell on DocuSign, Lowers Price Target to $45
Portfolio Pulse from richadhand@benzinga.com
UBS analyst Karl Keirstead maintains a Sell rating on DocuSign (NASDAQ:DOCU) and lowers the price target from $52 to $45.
May 31, 2023 | 12:37 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UBS analyst Karl Keirstead maintains a Sell rating on DocuSign and lowers the price target from $52 to $45.
The lowered price target by UBS analyst Karl Keirstead indicates a bearish outlook on DocuSign's stock. This news is likely to have a negative impact on the stock price in the short term as it suggests that the analyst believes the stock is overvalued at its current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100